Concepedia

Tingxi Guo

TG

Statistics

Publications

18

Citations

1.5K

H-Index

15

Active since

2015

Affiliations

University of Toronto(Current)

Princess Margaret Cancer Centre

University Health Network

Ontario Institute for Cancer Research

Structural Genomics Consortium

Tingxi Guo is an author at University of Toronto specializing in immunology, life sciences, and immunotherapy.

ORCID

Publications per year

2015–2024

18

Publications

18

A novel chimeric antigen receptor containing a JAK–STAT signaling domain mediates superior antitumor effects

Yuki Kagoya, Shinya Tanaka, Tingxi Guo et al. · Nature Medicine · 2018 · 600 citations

, , +14

BET bromodomain inhibition enhances T cell persistence and function in adoptive immunotherapy models

Yuki Kagoya, Munehide Nakatsugawa, Yūki Yamashita et al. · Journal of Clinical Investigation · 2016 · 215 citations · Full text

, , +17

Genetic Ablation of HLA Class I, Class II, and the T-cell Receptor Enables Allogeneic T Cells to Be Used for Adoptive T-cell Therapy

Yuki Kagoya, Tingxi Guo, Brian Yeung et al. · Cancer Immunology Research · 2020 · 176 citations

, , +17

Transient stimulation expands superior antitumor T cells for adoptive therapy

Yuki Kagoya, Munehide Nakatsugawa, Toshiki Ochi et al. · JCI Insight · 2017 · 60 citations · Full text

, , +16

GNTI-122: an autologous antigen-specific engineered Treg cell therapy for type 1 diabetes

Gene Uenishi, Marko Repic, Jennifer Yam et al. · JCI Insight · 2024 · 50 citations · Full text

, , +17

1–5 of 18